Frazier Financial Advisors’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$24.9K Sell
59
-63
-52% -$25.1K 0.01% 287
2026
Q2
$44.2K Sell
122
-45
-27% -$15.4K 0.02% 200
2026
Q1
$58.8K Buy
167
+90
+117% +$32.1K 0.03% 170
2025
Q4
$25.2K Sell
77
-340
-82% -$108K 0.01% 245
2025
Q3
$118K Sell
417
-96
-19% -$27.8K 0.07% 86
2025
Q2
$143K Buy
513
+158
+45% +$44.8K 0.1% 78
2025
Q1
$111K Buy
355
+43
+14% +$12.7K 0.09% 80
2024
Q4
$80.9K Buy
312
+6
+2% +$1.78K 0.06% 97
2024
Q3
$98.6K Buy
306
+296
+2,960% +$96.8K 0.08% 94
2024
Q2
$3.12K Sell
10
-6
-38% -$1.76K ﹤0.01% 728
2024
Q1
$4.55K Buy
+16
New +$4.68K ﹤0.01% 619

Other funds holding AMGN

Frazier Financial Advisors's AMGN Position: Q3 2026 in Review

Frazier Financial Advisors reduced its Amgen (AMGN) stake by 52% in Q3 2026, selling an estimated $25.1K and leaving 59 shares worth $24.9K. The position accounts for 0.01% of the portfolio, ranked #287.

Frazier Financial Advisors first reported a position in AMGN in Q1 2024 and has held it in 11 quarters since. The position peaked at $143K in Q2 2025. 3,271 funds tracked by Wall St. Rank hold AMGN as of Q3 2026.

  • Frazier Financial Advisors held 59 shares of Amgen worth $24.9K as of Q3 2026.
  • Frazier Financial Advisors sold 63 Amgen shares in Q3 2026, an estimated $25.1K.
  • Amgen made up 0.01% of Frazier Financial Advisors's portfolio in Q3 2026, its #287 holding.
  • Frazier Financial Advisors first reported a position in Amgen in Q1 2024 and has held it in 11 quarters since.
  • Frazier Financial Advisors's Amgen position peaked at $143K in Q2 2025.
  • 3,271 funds tracked by Wall St. Rank held Amgen as of Q3 2026.

Based on Frazier Financial Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.